These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4168936)

  • 21. Use of thin-layer chromatography for the preliminary diagnosis of Refsum's disease (Heredopathia atactica polyneuritiformis).
    Karlsson KA; Norrby A; Samuelsson B
    Biochim Biophys Acta; 1967 Aug; 144(1):162-4. PubMed ID: 4168043
    [No Abstract]   [Full Text] [Related]  

  • 22. Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease.
    Baxter JH
    J Lipid Res; 1968 Sep; 9(5):636-41. PubMed ID: 4177872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease).
    Eldjarn L; Try K; Stokke O
    Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999
    [No Abstract]   [Full Text] [Related]  

  • 24. Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease.
    Krauß S; Michaelis L; Vetter W
    PLoS One; 2017; 12(11):e0188035. PubMed ID: 29131855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 26. Different ratios of the LDD and DDD diastereoisomers of phytanic acid in patients with Refsum's disease.
    Eldjarn L; Try K
    Biochim Biophys Acta; 1968 Sep; 164(1):94-100. PubMed ID: 4176022
    [No Abstract]   [Full Text] [Related]  

  • 27. Refsum's syndrome.
    Levy IS
    Trans Ophthalmol Soc U K (1962); 1970; 90():181-6. PubMed ID: 4104195
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
    ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
    Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
    Yao JK; Dyck PJ
    Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of phytanic and linoleic acid into plasma lipids in Refsum's disease.
    Laurell S; Nilsén R; Nordén A
    Clin Chim Acta; 1972 Jan; 36(1):169-74. PubMed ID: 4109168
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of novel branched-chain fatty acids in Refsum's disease.
    Dulaney JT; Williams M; Evans JE; Costello CE; Kolodny EH
    Biochim Biophys Acta; 1978 Apr; 529(1):1-12. PubMed ID: 76480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Distribution of phytanic esters among the serum triglycerides of 5 patients with Refsum's syndrome. A study with thin layer chromatography].
    Laudat P; Wolf LM
    Biochim Biophys Acta; 1969 Mar; 176(2):425-8. PubMed ID: 4180409
    [No Abstract]   [Full Text] [Related]  

  • 33. Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.
    Steinberg D; Mize CE; Herndon JH; Fales HM; Engel WK; Vroom FQ
    Arch Intern Med; 1970 Jan; 125(1):75-87. PubMed ID: 4188898
    [No Abstract]   [Full Text] [Related]  

  • 34. Nutritional and metabolic aspects of heredopathia atactica polyneuritiformis (Refsum's syndrome).
    Lenk W
    Nutr Metab; 1974; 16(6):366-74. PubMed ID: 4135766
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phytol intolerance: Refsum's disease].
    Laudat P
    Biochimie; 1972; 54(5):735-40. PubMed ID: 4120186
    [No Abstract]   [Full Text] [Related]  

  • 36. [Phytol and phytanic acid in 2 cases of hereditary chronic polyneuropathy with uncertain classification: correlations with Refsum's disease].
    Livrea P
    Acta Neurol (Napoli); 1973; 28(1):47-59. PubMed ID: 4122245
    [No Abstract]   [Full Text] [Related]  

  • 37. The ability of patients with herdopathia atactica polyneuritiformis to alpha-oxidize and degrade several isoprenoid branch-chained fatty structures.
    Eldjarn L; Try K; Stokke O
    Scand J Clin Lab Invest; 1966; 18(2):141-50. PubMed ID: 4161956
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipid studies in organs of a child with Refsum's syndrome].
    Kremer GJ
    Klin Wochenschr; 1966 Sep; 44(18):1089-92. PubMed ID: 4170326
    [No Abstract]   [Full Text] [Related]  

  • 39. The degradation of a branched chain fatty acid by alternations between alpha- and beta-oxidations.
    Stokke O
    Biochim Biophys Acta; 1969 Jan; 176(1):54-9. PubMed ID: 5766028
    [No Abstract]   [Full Text] [Related]  

  • 40. Refsum's syndrome. Heredopathia atactica polyneuritiformis.
    Nevin NC; Cumings JN; McKeown F
    Brain; 1967 Jun; 90(2):419-28. PubMed ID: 4165695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.